Clinical trial
The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population
NCT02118532 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population
- Lead sponsor
- Medtronic Endovascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- September 30, 2016
- Enrollment
- 143 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.